Morisawa T et al. |
Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease. |
2015 |
Int Heart J |
pmid:26549398
|
Beuselinck B et al. |
RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs. |
2015 |
Br. J. Cancer |
pmid:26528707
|
Rewiuk K and Grodzicki T |
Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. |
2015 |
Biomed Res Int |
pmid:26504794
|
Pitari MR et al. |
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. |
2015 |
Oncotarget |
pmid:26160841
|
Hsu BG et al. |
High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. |
2015 |
Tohoku J. Exp. Med. |
pmid:26156285
|
Wei J et al. |
Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. |
2015 |
Mol Med Rep |
pmid:25891179
|
Su F et al. |
Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. |
2015 |
Stem Cell Res Ther |
pmid:25888745
|
Shen Y et al. |
(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. |
2015 |
BMC Complement Altern Med |
pmid:25887296
|
Son GY et al. |
Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. |
2015 |
J. Dent. Res. |
pmid:25595364
|
Oostra DR et al. |
Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. |
2015 |
Mol. Cell. Endocrinol. |
pmid:25575458
|